Does China improve social welfare after implementing the national volume-based procurement?
Objective: To explore the changes in social welfare before and after the implementation of the national volume-based procurement (NVBP). Explore whether the NVBP promotes the healthy development of manufacturers under the premise of benefiting patients. Then put forward relevant suggestions on how t...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1178026/full |
_version_ | 1797662080305725440 |
---|---|
author | Huan Wang Ya-Tong Huo Qian Zhuang |
author_facet | Huan Wang Ya-Tong Huo Qian Zhuang |
author_sort | Huan Wang |
collection | DOAJ |
description | Objective: To explore the changes in social welfare before and after the implementation of the national volume-based procurement (NVBP). Explore whether the NVBP promotes the healthy development of manufacturers under the premise of benefiting patients. Then put forward relevant suggestions on how to effectively intervene the government in the pharmaceutical market.Methods: Starting with consumer surplus and producer surplus, social welfare was studied from the three perspectives of price, supply, and demand.Results: Consumer surplus was significantly increased, and the drug welfare of patients was significantly improved. The profits of the whole pharmaceutical industry have decreased but will increase in the future. The welfare of individual pharmaceutical enterprises varies. Overall social welfare has been significantly improved.Conclusion: The core purpose of the NVBP is to improve the medication welfare of patients, and through the increase of consumer surplus, it can affect the increase of producer surplus. Under such a linkage mechanism, the diversified linkage system of “price, demand, and supply” will achieve the effect of “1 + 1+1 > 3”. |
first_indexed | 2024-03-11T18:54:56Z |
format | Article |
id | doaj.art-c45a6b01566f494fb12fc9a9b4a6c6d2 |
institution | Directory Open Access Journal |
issn | 1663-9812 |
language | English |
last_indexed | 2024-03-11T18:54:56Z |
publishDate | 2023-10-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Pharmacology |
spelling | doaj.art-c45a6b01566f494fb12fc9a9b4a6c6d22023-10-11T06:54:17ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122023-10-011410.3389/fphar.2023.11780261178026Does China improve social welfare after implementing the national volume-based procurement?Huan WangYa-Tong HuoQian ZhuangObjective: To explore the changes in social welfare before and after the implementation of the national volume-based procurement (NVBP). Explore whether the NVBP promotes the healthy development of manufacturers under the premise of benefiting patients. Then put forward relevant suggestions on how to effectively intervene the government in the pharmaceutical market.Methods: Starting with consumer surplus and producer surplus, social welfare was studied from the three perspectives of price, supply, and demand.Results: Consumer surplus was significantly increased, and the drug welfare of patients was significantly improved. The profits of the whole pharmaceutical industry have decreased but will increase in the future. The welfare of individual pharmaceutical enterprises varies. Overall social welfare has been significantly improved.Conclusion: The core purpose of the NVBP is to improve the medication welfare of patients, and through the increase of consumer surplus, it can affect the increase of producer surplus. Under such a linkage mechanism, the diversified linkage system of “price, demand, and supply” will achieve the effect of “1 + 1+1 > 3”.https://www.frontiersin.org/articles/10.3389/fphar.2023.1178026/fullChinese drug policynational volume-based procurementsocial welfareconsumer surplusproducer surplusdrug welfare |
spellingShingle | Huan Wang Ya-Tong Huo Qian Zhuang Does China improve social welfare after implementing the national volume-based procurement? Frontiers in Pharmacology Chinese drug policy national volume-based procurement social welfare consumer surplus producer surplus drug welfare |
title | Does China improve social welfare after implementing the national volume-based procurement? |
title_full | Does China improve social welfare after implementing the national volume-based procurement? |
title_fullStr | Does China improve social welfare after implementing the national volume-based procurement? |
title_full_unstemmed | Does China improve social welfare after implementing the national volume-based procurement? |
title_short | Does China improve social welfare after implementing the national volume-based procurement? |
title_sort | does china improve social welfare after implementing the national volume based procurement |
topic | Chinese drug policy national volume-based procurement social welfare consumer surplus producer surplus drug welfare |
url | https://www.frontiersin.org/articles/10.3389/fphar.2023.1178026/full |
work_keys_str_mv | AT huanwang doeschinaimprovesocialwelfareafterimplementingthenationalvolumebasedprocurement AT yatonghuo doeschinaimprovesocialwelfareafterimplementingthenationalvolumebasedprocurement AT qianzhuang doeschinaimprovesocialwelfareafterimplementingthenationalvolumebasedprocurement |